Research Article
Data-Driven Discovery of Molecular Targets for Antibody-Drug Conjugates in Cancer Treatment
Table 1
Characteristics of patients with urothelial carcinoma for experimental validation of two FDA-approved targets.
| Characteristics | () |
| Age, | |
| Mean (SD), years | 68.03 (10.15) | Sex, (%) | |
| Female | 7 (10.3) |
| Male | 61 (89.7) | T stage, (%) | |
| T2 | 44 (64.7) |
| T3 | 19 (27.9) |
| T4a | 5 (7.4) | Tumor grade, (%) | |
| Low | 3 (4.4) |
| High | 65 (95.6) | N status, (%) | |
| Negative | 55 (80.9) |
| Positive | 13 (19.1) |
|
|
Abbreviation: SD: standard deviation.
|